What companies are PRME's competitors?

Prime Medicine, Inc. (PRME)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does PRME compare to its peers?

The peer comparison table on this page shows Prime Medicine, Inc. (PRME) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does PRME operate in?

Prime Medicine, Inc. (PRME) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

PRME

Prime Medicine, Inc.

NASDAQ·Biotechnology · Healthcare

$5.18$0.83+18.97%

Market cap$938.63M·Oct 28 2:54 PM EDT

Frequently Asked Questions About PRME

What companies are PRME's competitors?: Prime Medicine, Inc. (PRME)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does PRME compare to its peers?: The peer comparison table on this page shows Prime Medicine, Inc. (PRME) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does PRME operate in?: Prime Medicine, Inc. (PRME) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

PRME

Prime Medicine, Inc.

NASDAQ·Biotechnology · Healthcare

$5.18$0.83+18.97%

Market cap$938.63M·Oct 28 2:54 PM EDT

Peers

Sort:


CRSPCRSPCRISPR Therapeutics AG	CRISPR Therapeutics AG	$51.58	$5.0B
BEAMBEAMBeam Therapeutics Inc.	Beam Therapeutics Inc.	$28.39	$2.9B
NTLANTLAIntellia Therapeutics, Inc.	Intellia Therapeutics, Inc.	$12.96	$1.8B
DSGNDSGNDesign Therapeutics, Inc.	Design Therapeutics, Inc.	$10.89	$681.5M
EDITEDITEditas Medicine, Inc.	Editas Medicine, Inc.	$2.90	$445.4M
SCTXSCTXScribe Therapeutics Inc.	Scribe Therapeutics Inc.	$16.70	$270.2M
CRBUCRBUCaribou Biosciences, Inc.	Caribou Biosciences, Inc.	$0.48	$50.9M
MGXMGXMetagenomi, Inc. Common Stock	Metagenomi, Inc. Common Stock	$0.82	$30.8M

Frequently Asked Questions About PRME

What companies are PRME's competitors?: Prime Medicine, Inc. (PRME)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does PRME compare to its peers?: The peer comparison table on this page shows Prime Medicine, Inc. (PRME) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does PRME operate in?: Prime Medicine, Inc. (PRME) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.